Identifying Patients With Ischemic Heart Disease in an Electronic Medical Record

Size: px
Start display at page:

Download "Identifying Patients With Ischemic Heart Disease in an Electronic Medical Record"

Transcription

1 Original Research Identifying Patients With Ischemic Heart Disease in an Electronic Medical Record Journal of Primary Care & Community Health 2(1) The Author(s) 2011 Reprints and permission: sagepub.com/journalspermissions.nav DOI: / Noah Ivers, MD, CCFP 1-3, Bogdan Pylypenko, BScN 2, and Karen Tu, MD, MSc, CCFP, FCFP 2-4 Abstract Purpose: Increasing utilization of electronic medical records (EMRs) presents an opportunity to efficiently measure quality indicators in primary care. Achieving this goal requires the development of accurate patient-disease registries. This study aimed to develop and validate an algorithm for identifying patients with ischemic heart disease (IHD) within the EMR. Methods: An algorithm was developed to search the unstructured text within the medical history fields in the EMR for IHD-related terminology. This algorithm was applied to a 5% random sample of adult patient charts (n = 969) drawn from a convenience sample of 17 Ontario family physicians. The accuracy of the algorithm for identifying patients with IHD was compared to the results of 3 trained chart abstractors. Results: The manual chart abstraction identified 87 patients with IHD in the random sample (prevalence = 8.98%). The accuracy of the algorithm for identifying patients with IHD was as follows: sensitivity = 72.4% (95% confidence interval [CI]: ); specificity = 99.3% (95% CI: ); positive predictive value = 91.3% (95% CI: ); negative predictive value = 97.3 (95% CI: ); and kappa = 0.79 (95% CI: ). Conclusions: Patients with IHD can be accurately identified by applying a search algorithm for the medical history fields in the EMR of primary care providers who were not using standardized approaches to code diagnoses. The accuracy compares favorably to other methods for identifying patients with IHD. The results of this study may aid policy makers, researchers, and clinicians to develop registries and to examine quality indicators for IHD in primary care. Keywords electronic medical record, administrative data, ischemic heart disease, chart audit Ischemic heart disease (IHD) is a leading cause of morbidity and mortality that is often managed in primary care; 1 however, recent evidence indicates a wide variability in the management of such patients. 2,3 The increasing use of electronic medical records (EMRs) could facilitate improved monitoring of patients with IHD. However, unlike the case of diabetes, where structured fields in the EMR (such as laboratory results and treatments) can be used to accurately identify patients, 5 using the EMR to develop a registry of IHD patients is difficult. 6 Therefore, in jurisdictions where providers are not incentivised to systematically code diagnoses, approaches to help identify patients with IHD are needed to facilitate quality improvement efforts. With this goal in mind, we developed and tested a novel EMR search algorithm focusing on the unstructured text in the medical history fields. We also examined whether searching for nitrate prescriptions in the EMR would increase the accuracy of identification of patients with IHD as has been proposed in similar studies. 8 Methods Setting As part of a study for the Canadian Cardiovascular Outcomes Research Team (CCORT), selected Ontario family physicians using Practice Solutions EMR share their data with researchers at the Institute for Clinical Evaluative Sciences (ICES) to create an Electronic Medical Record 1 Women s College Hospital, Toronto, Canada 2 Institute for Clinical Evaluative Sciences, Toronto, Canada 3 Department of Family and Community Medicine, University of Toronto, Canada 4 Toronto Western Hospital Family Health Team, University Health Network, Toronto, Canada Corresponding Author: Noah Ivers, Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5 noah.ivers@ices.on.ca

2 50 Journal of Primary Care & Community Health 2(1) Table 1. Initial Search Algorithm Applied to Medical History Fields in Electronic Medical Records IHD, ischemic heart disease ASHD, arteriosclerotic heart disease CAD, coronary artery disease Angina ACS, acute coronary syndrome MI, myocardial infarction, STEMI, NSTEMI, non-stemi, AMI PCI, percutaneous coronary intervention, coronary stent, coronary angioplasty CABG, coronary bypass graft surgery Administrative Data Linked Database (EMRALD). ICES is a prescribed entity under the province of Ontario s Personal Health Information Protection Act, which allows for the collection of individual level health information for use in planning and managing the health care system. Practice Solutions is Ontario s most used EMR system, with 46.2% of the market as of November Algorithm Development The search algorithm was developed between August 2009 and January 2010 and was conducted on the EMR charts from all active, rostered, adult patients in the EMRALD database at that time. Active was defined as having at least 2 visits within 3 years. These patients belonged to 39 community-based family physicians from across Ontario who had used the EMR for at least 2 years. The algorithm was developed using the SQL database management system, starting by applying the clinically derived list of terms in Table 1 to the free-text entries in the medical history fields ( problem list and past medical history ) of the EMR. This initial IHD-related dictionary was developed based on the clinical experience of the investigators. It was refined iteratively by applying the terms in a search of the medical history fields and then adding any new IHD-related terms discovered. Physicians rarely used structured entries (eg, ICD-9 code 413 for angina), and usually entered data into the medical history fields using free text. Idiosyncratic descriptors were common in the medical history fields, such as stent-lad (meaning angioplasty for the left anterior descending coronary artery). Therefore, the search algorithm was designed to find exact matches to phrases/ words/acronyms and also allow for some variation in syntax or spelling (eg, LAD-stent vs stent-lad, AMI vs A.M.I.). Many patients had multiple IHD-relevant descriptors. To illustrate, some patients had a history of myocardial infarction (MI) and a prior stent. Because it seemed likely that stent was another IHD-related term, it was added to the algorithm. In the next iteration, new patients were identified with stent as their only IHD descriptor. Search-term-exclusions were also added to the algorithm to remove terms when they were not related to IHD. For instance, stent would be excluded if adjacent to aneurysm because the stent was not necessary related to IHD. Similarly, bypass (as in coronary artery bypass) was included as a search term, but was excluded from the algorithm if near the term gastric. We tried to increase specificity by excluding words preceded by? or query or possible. We also excluded IHD-related words occurring next to mother/father and occurring next to the phrase no known. All such exclusions were developed inductively. The algorithm was refined iteratively until no new search terms or exclusions were uncovered. The refinement of the search algorithm was conducted by 2 of the investigators (Noah Ivers and Bogdan Pylypenko) and any disagreements were settled through discussion with all investigators. The final search algorithm has 317 search terms and automatically removes 52 exclusion terms. Our methods were very similar to Natural Language Processing approaches recently reported in the medical informatics literature. 9,10 In these papers, it is argued that using text-dictionaries with modifier detection is a simple but efficient approach, and that clinical expertise is needed to adjust the search terms used to find exact matches, similar matches, and exclusion terms for specific clinical domains and contexts. Although there are open-source software options to assist medical informatics professionals to develop algorithms for searching free-text (such as NegEx 11 for finding exclusions), we chose to avoid such software to ensure that our methods were accessible to those with a clinical or policy focus. We also developed an algorithm to search for nitrate prescriptions in the treatments field of the EMR. We counted patients as nitrate positive if they had 1 long-acting nitrate prescription and/or 2 or more prescriptions for short-acting nitrates. The requirement for 2 short-acting nitrates was implemented to try to eliminate patients who were prescribed a nitro-spray only once prior to a normal stress test. Validation Set The validation set was based on a 5% random sample of patients from the first 17 physicians to contribute data to EMRALD. The 5% random sample resulted in 969 patients. As described in a related paper, 12 3 trained abstractors reviewed the full text from the entire patient chart. Patients that had documented evidence of a MI, percutaneous coronary intervention (PCI), or coronary artery bypass graft (CABG), or had IHD documented in a specialist letter, in the medical history fields, or in the family physician s

3 Ivers et al. 51 Table 2. Accuracy of Four Different Search Algorithms for Identifying Patients With IHD Compared to Manual Abstracted Occurrences (N = 87) From a Random Sample of Primary Care Electronic Medical Records a Search Technique Sensitivity (%) Specificity (%) PPV (%) NPV (%) Kappa Initial search, medical history fields ONLY 26.4, ( ) 99.6, ( ) 85.2, ( ) 93.2, ( ) 0.37, ( ) Initial search PLUS Rx nitrate 40.2, ( ) 99.3, ( ) 85.4, ( ) 94.4, ( ) 0.52, Refined search, medical history fields ONLY 72.4, ( ) 99.6, ( ) 94.0, ( ) 97.3, ( ) 0.80, Refined search PLUS Rx nitrate 74.7, ( ) 99.3, ( ) 91.2, ( ) 97.6, ( ) 0.81, Abbreviations: IHD, ischemic heart disease; PPV, positive predictive value; NPV, negative predictive value. a Values are given, followed by exact 95% confidence intervals. progress notes were IHD positive. The intraobserver reliability was high, with kappa values exceeding Analysis We tested the initial, clinical terms only (Table 1) and the final, refined search algorithm, with and without a nitrate prescription, against the results from the manual abstraction. Sensitivity was calculated as the proportion of patients identified by the manual abstraction as having IHD (used as the reference standard), who also had IHD according to the algorithm. Specificity was calculated in the same manner except that it was based on individuals who were not identified as having IHD. Positive predictive value (PPV) was defined as the proportion of IHD patients identified by the algorithm that were also identified as IHD by the manual abstraction. Negative predictive value (NPV) was defined similarly for patients that did not have IHD. Kappa statistics for agreement between the results from the manual abstraction and from the algorithm data were also calculated. Exact confidence interval (CIs) were calculated for all proportions and tests of accuracy. All analyses were conducted using SAS version 9.2 (SAS Institute, Cary, NC). In a secondary analysis, we evaluated the algorithms in a practice of 6 physicians that were new to the EMRALD database. One researcher (Dr Ivers) manually audited the complete electronic charts of all patients identified by each algorithm as having IHD. If the manual abstraction suggested that the patient did not have IHD, that patient was considered a false positive. This project received ethics approval through Sunnybrook Health Sciences Centre Research Ethics Board. Results The manual chart abstraction of 969 randomly selected charts identified 87 patients meeting criteria for IHD (prevalence = 8.98%). Table 2 shows that the refined search algorithm outperforms the initial search terms, greatly improving sensitivity with limited change to specificity. The addition of nitrate prescriptions substantially increased sensitivity compared to the initial search terms, but had little impact on the diagnostic accuracy of the refined search algorithm. When the algorithms were applied to a new EMRALD practice, the prevalence of IHD in this practice was estimated to be 9.68% to 12.66%, depending on the algorithm used. Table 3 shows that the false positive rate ranged from 4.14% to 12.54%. Compared to the initial search terms, the refined search resulted in a lower false positive rate, while identifying more IHD patients. Of the extra patients identified by adding a search for nitrate prescriptions, 51.92% were false positives. Of these false positives, 62.96% represented patients who had a negative work-up (eg, investigations revealed normal coronary arteries), while 25.93% seemed to have received nitrates for either congestive heart failure or for refractory hypertension, rather than angina. Using the refined algorithm, 85.71% of the false positives had a negative workup and the others had no further evidence in the chart of IHD. Discussion The refined algorithm vastly outperformed a set of clinically derived search terms for identifying patients with IHD. Using the same set of manually abstracted charts, algorithms using administrative databases identify patients with IHD with sensitivity of 77.0% but a PPV of only 78.8%. 12 The approach described here has slightly lower sensitivity but much better PPV. The PPV is also superior to methods described in the UK. 7,8 When the refined algorithm was applied to a new set of over 3000 patient charts, the false positive rate was <5%. This low false positive rate suggests a clinically useful tool for practice-based quality improvement. Furthermore, this approach relies only on primary care clinical data and therefore may capture patients in the earlier stages of disease. 13 Another major advantage of this search technique is that it does not require interventions to standardize data. 14 A Norwegian study has previously found that the use of the International Classification for Primary Care (ICPC) system for diagnostic codes could identify 75% of patients in primary care with IHD, 15 but the ICPC is not in common

4 52 Journal of Primary Care & Community Health 2(1) Table 3. Audit of IHD Patients Identified by Each Algorithm in New Primary Care Practice Search Technique # IHD Patients (estimated prevalence) # False Positives (% false positive) Initial search, medical history fields ONLY 299 (9.68%) 17 (5.69%) Initial search PLUS Rx nitrate 351 (11.37%) 44 (12.54%) Refined search, medical history fields ONLY 338 (10.95%) 14 (4.14%) Refined search PLUS Rx nitrate 390 (12.66%) 41 (10.51%) Abbreviation: IHD, ischemic heart disease. use in North America. Internet-based tools have been shown in New Zealand 16 and Australia 17 to help EMR-using clinicians manage cardiovascular risk, but these required extra data entry into structured fields. Another option for creating a registry is to search for all patients prescribed a cardiovascular drug followed by a manual abstraction to confirm those with IHD. 18 The uptake of such methods by typical primary care providers with limited resources is uncertain. There are a number of limitations with this study. The accuracy of the algorithm depends on updated medical history fields, but there is some evidence that keeping up-todate patient profiles in an EMR can lead to improved processes of care for patients at risk of cardiovascular disease. 19 In this study, physicians appear to be proactively updating the medical history fields as patients present with new problems. In fact, this created an unexpected limitation most false positives occurred when physicians quickly added IHD to the patient s problem list and neglected to remove it when subsequent investigations were negative. In contrast, removal of IHD-related words from the algorithm when preceded by possible may have improved specificity at the expense of sensitivity. The overlap between the development and validation data sets was necessary to use data from as many physicians as possible in creating the search algorithm (thereby including as many idiosyncratic IHD descriptors as possible). Though this might falsely elevate specificity in our analysis, the secondary analysis applying the algorithm to an entirely new population was concordant with the initial results. Finally, although the algorithm was developed using the charts of physicians with a variety of characteristics from across the province, these were a convenience sample of participants all using the same software. These physicians are experienced EMR users and may be systematically different from other physicians with respect to how they populate the medical history fields. Therefore, application to other physicians using other EMR software may not have the same accuracy. The inclusion of billing/diagnostic codes, prescriptions other than nitrates, or cardiac investigations in an EMRbased search algorithm for IHD patients requires further investigation. In general, primary care providers in North America lag behind other developed countries with respect to utilization of EMRs, 1 due in part to a lack of standardized documentation procedures. Innovative approaches are needed to develop IHD patient registries and maximize the potential of EMRs. The approach described above compares favorably to other methods and could facilitate primary care physicians and researchers in using EMRs to facilitate quality improvement activities for patients with IHD. Acknowledgement The authors thank the physician participants of EMRALD. Declaration of Conflicting Interests The authors declared no potential conflicts of interests with respect to the authorship and/or publication of this article. Financial Disclosure/Funding This work was funded by a Canadian Institutes of Health Research Team grant in Cardiovascular Outcomes Research to the Canadian Cardiovascular Outcomes Research Team (CCORT). Dr Ivers is supported by a Fellowship Award in Primary Care from the Canadian Institutes of Health Research (CIHR). References 1. Schoen C, Osborn R, Doty MM, Squires D, Peugh J, Applebaum S. A survey of primary care physicians in eleven countries, 2009: Perspectives on care, costs, and experiences. Health Aff (Millwood). 2009;28:w1171-w DeWilde S, Carey IM, Richards N, Whincup PH, Cook DG. Trends in secondary prevention of ischaemic heart disease in the UK : use of individual and combination treatment. Heart. 2008;94: Austin PC, Tu JV, Ko DT, Alter DA. Factors associated with the use of evidence based therapies after discharge among elderly patients with myocardial infarction. CMAJ. 2008;179: Mitiku TF, Tu K. Using data from electronic medical records: theory versus practice. Healthc Q. 2008;11: Tu K, Manuel D, Lam K, Kavanagh D, Mitiku T, Guo H. Diabetics can be identified in an electronic medical record using lab tests and prescriptions. J Clin Epidemiol Fokkens AS, Wiegersma PA, Reijneveld SA. A structured registration program can be validly used for quality assessment in general practice. BMC Health Serv Res. 2009;9:241.

5 Ivers et al Gray J, Majeed A, Kerry S, Rowlands G. Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerized medical records. BMJ. 2000;321: Donnan PT, Dougall HT, Sullivan FM. Optimal strategies for identifying patients with myocardial infarction in general practice. Fam Pract. 2003;20: Farkas R, Szarvas G, Hegedus I, et al. Semi-automated construction of decision rules to predict morbidities from clinical texts. J Am Med Inform Assoc. 2009;16: Yang H, Spasic I, Keane JA, Nenadic G. A text mining approach to the prediction of disease status from clinical discharge summaries. J Am Med Inform Assoc. 2009;16: Chapman WW, Bridewell W, Hanbury P, Cooper GF, Buchanan BG. A simple algorithm for identifying negated findings and diseases in discharge summaries. J Biomed Inform. 2001;34: Tu K, Mitiku T, Lee DS, Guo H, Tu JV. Validation of physician billing and hospitalization data to identify patients with ischemic heart disease using EMRALD. Can J Cardiol. In press. 13. Elo SL, Karlberg IH. Validity and utilization of epidemiological data: a study of ischaemic heart disease and coronary risk factors in a local population. Public Health. 2009;123: de Lusignan S. An educational intervention, involving feedback of routinely collected computer data, to improve cardiovascular disease management in UK primary care. Methods Inf Med. 2007;46: Treweek S. The potential of electronic medical record systems to support quality improvement work and research in Norwegian general practice. BMC Health Serv Res. 2003;3: Wells S, Furness S, Rafter N, Horn E, Whittaker R, Stewart A, et al. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice. Eur J Cardiovasc Prev Rehabil. 2008;15: Peiris DP, Joshi R, Webster RJ, Groenestein P, Usherwood TP, Heeley E, et al. An electronic clinical decision support tool to assist primary care providers in cardiovascular disease risk management: development and mixed methods evaluation. J Med Internet Res. 2009;11:e Gray J, Ekins M, Scammell A, Carroll K, Majeed A. Workload implications of identifying patients with ischaemic heart disease in primary care: population-based study. J Public Health Med. 2003;25: Hartung DM, Hunt J, Siemienczuk J, Miller H, Touchette DR. Clinical implications of an accurate problem list on heart failure treatment. J Gen Intern Med. 2005;20: Bios Noah Ivers, MD, CCFP, is a primary care research fellow and a family physician at Women s College Hospital. Bogdan Pylypenko, BScN, is a health informatician at the Institute for Clinical Evaluative Sciences. Karen Tu, MD, MSc, CCFP, FCFP, is a family physician and a scientist at the Institute for Clinical Evaluative Sciences.

Using the electronic medical records to identify patients with hypertension in primary care: A validation study using EMRALD.

Using the electronic medical records to identify patients with hypertension in primary care: A validation study using EMRALD. Using the electronic medical records to identify patients with hypertension in primary care: A validation study using EMRALD. Noah Ivers, Bogdan Pylypenko, Karen Tu Presentation @ CAHSPR: May 10, 2011

More information

Karen Tu MD, MSc, CCFP, FCFP Scientist ICES Associate Professor DFCM, University of Toronto Active Staff Toronto Western Hospital FHT

Karen Tu MD, MSc, CCFP, FCFP Scientist ICES Associate Professor DFCM, University of Toronto Active Staff Toronto Western Hospital FHT Validation of administrative data algorithms to determine population prevalence and incidence of Alzheimer's disease, dementia, MS, epilepsy and Parkinson's disease Karen Tu MD, MSc, CCFP, FCFP Scientist

More information

Supplementary material

Supplementary material Supplementary material Validation procedures To validate the quality of the diagnostic information in the Beijing Hospital Discharge Information System (HDIS), 1069 patients with acute myocardial infarction

More information

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018 Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report May 2018 Prepared by the Canadian Cardiovascular Society (CCS)/Canadian Society of Cardiac Surgeons (CSCS) Cardiac

More information

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft Measure #43 (NQF 0134): Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS

More information

Chest pain and subsequent consultation for coronary heart disease:

Chest pain and subsequent consultation for coronary heart disease: Chest pain and subsequent consultation for coronary heart disease: a prospective cohort study Peter R Croft and Elaine Thomas ABSTRACT Background Chest pain may not be reported to general practice but

More information

Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction

Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction CMAJ Research Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction Peter C. Austin PhD, Jack V. Tu MD PhD, Dennis T. Ko MD MSc, David A. Alter MD PhD

More information

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Trends of acute myocardial infarction in Korea from the experience of Korea Acute

More information

Supplement materials:

Supplement materials: Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction

More information

Consensus Core Set: Cardiovascular Measures Version 1.0

Consensus Core Set: Cardiovascular Measures Version 1.0 Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for

More information

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group Repeat ischaemic heart disease audit of primary care patients (2002-2003): Comparisons by age, sex and ethnic group Baseline-repeat ischaemic heart disease audit of primary care patients: a comparison

More information

The CADScor System Frequently asked questions

The CADScor System Frequently asked questions 1 The CADScor System Frequently asked questions Clinical Usage...2 How can I use the CADScor System?... 2 Contra-indications for use... 2 What is the performance of the CADScor System?... 2 Table: Performance

More information

Surgery Grand Rounds

Surgery Grand Rounds Surgery Grand Rounds Coronary Artery Bypass Grafting versus Coronary Artery Stenting Charles Ted Lord, R1 Coronary Artery Disease Stenosis of epicardial vessels Metabolic & hematologic Statistics 500,000

More information

Declaration of conflict of interest. Nothing to disclose

Declaration of conflict of interest. Nothing to disclose Declaration of conflict of interest Nothing to disclose Hong-Seok Lim, Seung-Jea Tahk, Hyoung-Mo Yang, Jin-Woo Kim, Kyoung- Woo Seo, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Gyo-Seung Hwang, Joon-Han

More information

Inter-regional differences and outcome in unstable angina

Inter-regional differences and outcome in unstable angina European Heart Journal (2000) 21, 1433 1439 doi:10.1053/euhj.1999.1983, available online at http://www.idealibrary.com on Inter-regional differences and outcome in unstable angina Analysis of the International

More information

Coronary Revascularization Rates in Ontario: Which rate is right?

Coronary Revascularization Rates in Ontario: Which rate is right? Coronary Revascularization Rates in Ontario: Which rate is right? Jack V. Tu,, MD PhD FRCPC Division of General Internal Medicine, Sunnybrook & Women s College Health Science Centre University of Toronto

More information

Verwendung von routinemässig erhobenen Daten für pragmatische randomisierte Studien: Erste Erfahrungen in der Schweiz

Verwendung von routinemässig erhobenen Daten für pragmatische randomisierte Studien: Erste Erfahrungen in der Schweiz Verwendung von routinemässig erhobenen Daten für pragmatische randomisierte Studien: Erste Erfahrungen in der Schweiz Landesmuseum, Zürich, 21. November 2017 Prof. Dr. med. Heiner C. Bucher MPH Institut

More information

Supplementary Material to Mayer et al. A comparative cohort study on personalised

Supplementary Material to Mayer et al. A comparative cohort study on personalised Suppl. Table : Baseline characteristics of the patients. Characteristic Modified cohort Non-modified cohort P value (n=00) Age years 68. ±. 69.5 ±. 0. Female sex no. (%) 60 (0.0) 88 (.7) 0.0 Body Mass

More information

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood Revascularization In HFrEF: Are We Close To The Truth Ali Almasood HF epidemic 1-2% of the population have HF At least one-half have heart failure with reduced ejection fraction (HF- REF) The most common

More information

New Insight about FFR and IVUS MLA

New Insight about FFR and IVUS MLA New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR

More information

Retrieving disorders and findings: Results using SNOMED CT and NegEx adapted for Swedish

Retrieving disorders and findings: Results using SNOMED CT and NegEx adapted for Swedish Retrieving disorders and findings: Results using SNOMED CT and NegEx adapted for Swedish Maria Skeppstedt 1,HerculesDalianis 1,andGunnarHNilsson 2 1 Department of Computer and Systems Sciences (DSV)/Stockholm

More information

The Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University

The Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University The Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University Expert Opinions CCS Vancouver, BC October 23, 2011 Overview of ACS Epidemiology: Global

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

National Cardiovascular Data Registry

National Cardiovascular Data Registry National Cardiovascular Data Registry Young and Early Career Investigators ACC/AGS/NIA Multimorbidity in Older Adults with Cardiovascular Disease Workshop Ralph Brindis, MD MPH Senior Medical Officer,

More information

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009 Western University Scholarship@Western Electronic Thesis and Dissertation Repository June 2015 Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009 Ngan Lam The University

More information

Alex versus Xience Registry Preliminary report

Alex versus Xience Registry Preliminary report Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor

More information

Δημήτριος Αγγοσράς, FETCS

Δημήτριος Αγγοσράς, FETCS ΣΕΜΙΝΑΡΙΟ ΟΜΑΔΩΝ ΕΡΓΑΣΙΑΣ Δημήτριος Αγγοσράς, FETCS Επίκοσρος Καθηγηηής Καρδιοτειροσργικής Ιαηρική Πανεπιζηημίοσ Αθηνών Πανεπιζηημιακό Γενικό Νοζοκομείο Αηηικόν Randomized Controlled Trials (RCTs) Why

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of

More information

Amjed Kadhim-Saleh, BHSc, MSc, Michael Green, MD, MPH, Tyler Williamson, PhD, Duncan Hunter, PhD, and Richard Birtwhistle, MD, MSc

Amjed Kadhim-Saleh, BHSc, MSc, Michael Green, MD, MPH, Tyler Williamson, PhD, Duncan Hunter, PhD, and Richard Birtwhistle, MD, MSc ORIGINAL RESEARCH Validation of the Diagnostic Algorithms for 5 Chronic Conditions in the Canadian Primary Care Sentinel Surveillance Network (CPCSSN): A Kingston Practice-based Research Network (PBRN)

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

Lessons learned From The National PCI Registry

Lessons learned From The National PCI Registry Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients

More information

Accepted Manuscript. Radial artery and bilateral mammary arteries in CABG: how much is too much? Derrick Y. Tam, MD, Stephen E.

Accepted Manuscript. Radial artery and bilateral mammary arteries in CABG: how much is too much? Derrick Y. Tam, MD, Stephen E. Accepted Manuscript Radial artery and bilateral mammary arteries in CABG: how much is too much? Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc PII: S0022-5223(19)30032-7 DOI: https://doi.org/10.1016/j.jtcvs.2019.01.009

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency Quality ID #323: Cardiac Stress Imaging t Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI) National Quality Strategy Domain: Efficiency and Cost Reduction

More information

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained? TROPONIN POSITIVE WHAT DOES IT MEAN? Frequently Asked Questions Regarding the Use of Troponin in the Clinical Setting What does an elevated troponin level mean? Elevated troponin is a sensitive and specific

More information

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT01724957 Dobrin Vassilev MD, PhD Assoc. Prof. in Cardiology Head Cardiology Clinic, Alexandrovska University Hospital Medical

More information

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά International ACS guidelines: Recommendations on duration of dual

More information

NHS Dumfries & Galloway Aspirin Discontinuation Audit May 2011 (updated August 2015)

NHS Dumfries & Galloway Aspirin Discontinuation Audit May 2011 (updated August 2015) Title of Project: NHS Dumfries & Galloway Aspirin Discontinuation Audit May 2011 (updated August 2015) 1 Reason for the review In the UK, low dose aspirin (75mg) is licensed for the prevention of thrombotic

More information

Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998

Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998 Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998 CARDIOVASCULAR DISEASE is the leading cause of death in Australia, causing more than 40% of all deaths in 1998. 1 Cardiac rehabilitation

More information

Declaration of conflict of interest NONE

Declaration of conflict of interest NONE Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages

More information

Competency Portfolio for the Diploma in Adult Interventional Cardiology

Competency Portfolio for the Diploma in Adult Interventional Cardiology Competency Portfolio for the Diploma in Adult Interventional Cardiology For Candidates to Complete 2013 VERSION 2.1 This portfolio applies to those who begin training on or after July 1 st, 2013. DEFINITION

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #323: Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI) National Quality Strategy Domain: Efficiency and Cost Reduction

More information

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events. ACETYL SALICYLIC ACID TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

More information

Mode of admission and its effect on quality indicators in Belgian STEMI patients

Mode of admission and its effect on quality indicators in Belgian STEMI patients 2015 Mode of admission and its effect on quality indicators in Belgian STEMI patients Prof dr M Claeys National Coordinator STEMI registry 29-6-2015 Background The current guidelines for the management

More information

Patient characteristics Intervention Comparison Length of followup

Patient characteristics Intervention Comparison Length of followup ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing

More information

Report on Coronary Artery Bypass Surgery in Ontario, Fiscal Years 2005/06 and 2006/07

Report on Coronary Artery Bypass Surgery in Ontario, Fiscal Years 2005/06 and 2006/07 Evidence guiding health care Report on Coronary Artery Bypass Surgery in Ontario, Fiscal Years 2005/06 and 2006/07 In collaboration with the Cardiac Care Network of Ontario July 2008 Report on Coronary

More information

Notes Indicate to the group that this patient will be the focus of today s case discussion.

Notes Indicate to the group that this patient will be the focus of today s case discussion. 1 Indicate to the group that this patient will be the focus of today s case discussion. Read out the case authors and their disclosure information. Instructions Fill out prior to the meeting and disclose

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for

More information

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute Chronic Total Occlusions Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute Financial Disclosures /see -tee-oh / abbr. Med. Chronic Total Occlusion,

More information

Ischaemic cardiovascular disease

Ischaemic cardiovascular disease Ischaemic cardiovascular disease What are the PHO performance programme indicators and how are they best achieved? 40 BPJ Issue 36 Supporting the PHO Performance Programme The PHO Performance Programme

More information

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice 10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice Ajar Kochar, MD on behalf of: Anita Y. Chen, Puza P. Sharma, Neha J. Pagidipati, Gregg C. Fonarow, Patricia

More information

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict

More information

CLINICAL CONSEQUENCES OF THE

CLINICAL CONSEQUENCES OF THE CLINICAL CONSEQUENCES OF THE FAME STUDY TCT ASIA Seoul, Korea, april 26 th, 2012 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands GUIDELINES ESC SEPTEMBER 2010 FFR UPGRADED TO LEVEL

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #44 (NQF 0236): Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

The validity of the diagnosis of inflammatory arthritis in a large population-based primary care database

The validity of the diagnosis of inflammatory arthritis in a large population-based primary care database Nielen et al. BMC Family Practice 2013, 14:79 RESEARCH ARTICLE Open Access The validity of the diagnosis of inflammatory arthritis in a large population-based primary care database Markus MJ Nielen 1*,

More information

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology STEMI update Vijay Krishnamoorthy M.D. Interventional Cardiology OVERVIEW Current Standard of Care in Management of STEMI Update in management of STEMI Pre-Cath Lab In the ED/Office/EMS. Cath Lab Post

More information

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS Coronary Physiology In The Cathlab FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS Educational Training Program ESC European Heart House april 7th 9th 2011 Nico H.J.Pijls, MD, PhD Catharina Hospital,

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor

More information

AHA Clinical Science Special Report: November 10, 2015

AHA Clinical Science Special Report: November 10, 2015 www.canheart.ca High-density lipoprotein cholesterol and cause-specific mortality: A population-based study of more than 630,000 individuals without prior cardiovascular conditions Dennis T. Ko, MD, MSc;

More information

CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study. Results at 1 Year

CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study. Results at 1 Year CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study Results at 1 Year André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Query Refinement: Negation Detection and Proximity Learning Georgetown at TREC 2014 Clinical Decision Support Track

Query Refinement: Negation Detection and Proximity Learning Georgetown at TREC 2014 Clinical Decision Support Track Query Refinement: Negation Detection and Proximity Learning Georgetown at TREC 2014 Clinical Decision Support Track Christopher Wing and Hui Yang Department of Computer Science, Georgetown University,

More information

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals. OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To review the use of antiplatelet agents and oral

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

RIC Remote Ischemic Conditioning to reduce reperfusion injury during acute STEMI: A systematic review and meta-analysis

RIC Remote Ischemic Conditioning to reduce reperfusion injury during acute STEMI: A systematic review and meta-analysis RIC Remote Ischemic Conditioning to reduce reperfusion injury during acute STEMI: A systematic review and meta-analysis [McLeod SL, Iansavitchene A, Cheskes S] Sheldon Cheskes, MD CCFP(EM) FCFP Medical

More information

COURAGE to Leave Diseased Arteries Alone

COURAGE to Leave Diseased Arteries Alone COURAGE to Leave Diseased Arteries Alone Spencer King MD MACC, FSCAI St. Joseph s s Heart and Vascular Institute Professor of Medicine Emeritus Emory Univ. Atlanta, USA Conflict: I am an Interventionalist

More information

CLINICAL PROCESS IMPROVEMENT INITIATIVE (CPII) EFFICIENCY REPORT EXPLANATION January 4, 2016

CLINICAL PROCESS IMPROVEMENT INITIATIVE (CPII) EFFICIENCY REPORT EXPLANATION January 4, 2016 CLINICAL PROCESS IMPROVEMENT INITIATIVE (CPII) EFFICIENCY REPORT EXPLANATION January 4, 2016 WHAT IS AN EPISODE OF CARE? An episode of care is a grouping of a patient s health care claims for a unique

More information

Validating and Reporting the 2017 UDS Clinical Measures (Version 1)

Validating and Reporting the 2017 UDS Clinical Measures (Version 1) Validating and Reporting the 2017 UDS Clinical Measures Author: Ben Fouts, Informatics Redwood Community Health Coalition 1310 Redwood Way Petaluma, California 94954 support@rchc.net Document Last Updated:

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis

More information

Cardiac Rehabilitation after Primary Coronary Intervention CONTRA

Cardiac Rehabilitation after Primary Coronary Intervention CONTRA DEBATE SESSION Is there a role for cardiac rehabilitation in the modern era of Percutaneous coronary intervention and coronary artery bypass grafting? Cardiac Rehabilitation after Primary Coronary Intervention

More information

HEALTH SYSTEM MATRIX VERSION 8.0 DATA DICTIONARY

HEALTH SYSTEM MATRIX VERSION 8.0 DATA DICTIONARY HEALTH SYSTEM MATRIX VERSION 8.0 DATA DICTIONARY A. TIME AND PERSON IDENTIFIERS Time Identifier FISCAL_YEAR Fiscal Year (runs from April 1st to March 31st of next calendar year). The Health System Matrix

More information

Coronary Plaque Sealing: The DEFER Study and more...

Coronary Plaque Sealing: The DEFER Study and more... Coronary Plaque Sealing: The DEFER Study and more... How Waiting Can Be Beneficial in Stable Coronary Artery Disease Patients ESC, Stockholm, 2005 M. Romanens, 21.09.2005 at www.kardiolab.ch DEFER Study:

More information

DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI

DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, G. PAPANIKOLAOU GH, THESSALONIKI The Impact of AF on Natural History of CAD DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI CAD MOST COMMON CARDIOVASCULAR DISEASE MOST COMMON CAUSE OF DEATH

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

Does quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)?

Does quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)? Does quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)? Erika Friedmann a, Eleanor Schron, b Sue A. Thomas a a University of Maryland School of Nursing; b NEI, National

More information

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016 TYPE II MI KC ACDIS LOCAL CHAPTER March 8, 2016 TYPE 2 MI DEFINITION: Acute coronary syndrome (ACS) encompasses a continuum of myocardial ischemia and infarction, which can make the diagnostic and coding

More information

Clopidogrel has been evaluated in clinical trials that included cardiovascular patients

Clopidogrel has been evaluated in clinical trials that included cardiovascular patients REVIEW ARTICLE Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations Lessons From the CAPRIE and CURE Studies Jack Hirsh, CM, MD, FRCPC, FRACP, FRSC, DSc; Deepak L. Bhatt, MD,

More information

2017 Cardiology Survival Guide

2017 Cardiology Survival Guide 2017 Cardiology Survival Guide Chapter 4: Cardiac Catheterization/Percutaneous Coronary Intervention A cardiac catheterization involves a physician inserting a thin plastic tube (catheter) into an artery

More information

Appendix 1 (as supplied by the authors): Databases and definitions used.

Appendix 1 (as supplied by the authors): Databases and definitions used. Appendix 1 (as supplied by the authors): Databases and definitions used. Table e1: The Institute for Clinical Evaluative Sciences databases used in this study and their descriptions Database Ontario Health

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Measure #445 (NQF 0119): Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG) National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.

More information

Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents

Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents Dennis T. Ko, MD, MSc, a,b Maria Chiu, MSc, b Helen Guo, MSc, b Peter

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pincus D, Ravi B, Wasserstein D. Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA. doi: 10.1001/jama.2017.17606 eappendix

More information

INDIVIDUALIZED MEDICINE

INDIVIDUALIZED MEDICINE CENTER FOR INDIVIDUALIZED MEDICINE Clopidogrel Pharmacogenetics Can We Impact Clinical Practice? Michael E. Farkouh, MD, MSc Peter Munk Cardiac Centre University of Toronto Naveen Pereira MD Mayo Clinic

More information

THE NATIONAL QUALITY FORUM

THE NATIONAL QUALITY FORUM THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Measure #204 (NQF 0068): Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

APPROACH WORKING REPORT

APPROACH WORKING REPORT APPROACH WORKING REPORT Diagnostic Cardiac Catheterization and Revascularization Rates for Coronary Heart Disease in Alberta Regional Health Authorities from 1995 to 2002 (Version 1). May 6, 2005 ACKNOWLEDGEMENTS

More information

Why and How Should We Switch Clopidogrel to Prasugrel?

Why and How Should We Switch Clopidogrel to Prasugrel? Case Presentation Why and How Should We Switch Clopidogrel to Prasugrel? Shaul Atar Western Galilee Medical Center Nahariya, ISRAEL Case Description A 67 Y. Old Pt. admitted to IM with anginal CP. DM,

More information

TRIAL UPDATE 1. ISAR TRIPLE SECURITY Trial. Dr Deven Patel Royal Free Hospital

TRIAL UPDATE 1. ISAR TRIPLE SECURITY Trial. Dr Deven Patel Royal Free Hospital TRIAL UPDATE 1 ISAR TRIPLE SECURITY Trial Dr Deven Patel Royal Free Hospital NO CONFLICT OF INTEREST TO DECLARE ISAR TRIPLE Comparison of 6 weeks vs 6 months Triple Therapy in patients on oral anticoagulation

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

Validation of Carotid Artery Revascularization Coding in Ontario Health Administrative Databases

Validation of Carotid Artery Revascularization Coding in Ontario Health Administrative Databases ORIGINAL RESEARCH Mohamad A. Hussain, MD 1,5 Muhammad Mamdani, PharmD, MA, MPH 4,7,8,9,10,11 Gustavo Saposnik MD, MSc 2,4,6,7,11 Jack V. Tu, MD, PhD 6,7,11,12 David Turkel-Parrella, MD 3 Julian Spears,

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

A.K. Gitt, F. Towae, C. Juenger, A. Papp, R. Zahn, U. Zeymer, J. Senges For the STAR-Study-Group Herzzentrum Ludwigshafen, Germany

A.K. Gitt, F. Towae, C. Juenger, A. Papp, R. Zahn, U. Zeymer, J. Senges For the STAR-Study-Group Herzzentrum Ludwigshafen, Germany Impact of Interventional Versus Conservative Approach on 5-Year-Mortality of Patients With Stable Angina and Documented Coronary Artery Disease in Clinical Practice: Results of the STAR-Registry A.K. Gitt,

More information

The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention. Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager

The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention. Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager Objectives Core Components of Cardiac Rehab Program CR Indications &

More information